Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer
Academic Article
Overview
MeSH Major
Carcinoma, Non-Small-Cell Lung
Induction Chemotherapy
Lung Neoplasms
Lymph Nodes
Neoadjuvant Therapy
Positron-Emission Tomography
abstract
Postinduction PET avidity for N2 nodes is not associated with ypN2 disease, overall survival, or disease-free survival in patients undergoing induction chemotherapy for stage IIIA/pN2 disease.